Curis (CRIS) Payables (2010 - 2026)

Curis (CRIS) reported Payables of $6.7 million for Q1 2026, up 32.09% on a YoY basis from $5.1 million in Q1 2025, and up 20.14% quarter-over-quarter from $5.6 million in Q4 2025.

Curis (CRIS) Payables (2010 - 2026) Analysis & Trends

Curis has reported Payables for 17 years, with the latest figure at $6.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Payables rose 32.09% year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (up 32.09% YoY), and the FY2025 full-year result was $5.6 million, up 85.58% from the prior year.
  • Payables for Q1 2026 stood at $6.7 million, up from $5.6 million in the prior quarter.
  • The five-year high for Payables was $6.7 million in Q1 2026, with the low at $2.4 million in Q2 2024.
  • Historically, Payables has averaged $4.2 million across 5 years, with a median of $4.1 million in 2025.
  • Annual changes were most pronounced in 2023 — Payables sank 51.26% — and 2025, when it jumped 85.58%.
  • Curis' Payables stood at $3.2 million in 2022, then dropped by 0.66% to $3.2 million in 2023, then decreased by 4.67% to $3.0 million in 2024, then jumped by 85.58% to $5.6 million in 2025, then rose by 20.14% to $6.7 million in 2026.
  • The last three Payables figures came in at $6.7 million (Q1 2026), $5.6 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 1.05 Mn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 300,549.00
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 83.00 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 8.69 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 489.30 Mn
9 Abivax 95.45 Bn 95.45 Bn - 34.55 Mn
10 Curis 8.58 Mn -6.42 Mn - 6.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.74 Mn
Dec 31, 2025 5.61 Mn
Sep 30, 2025 4.45 Mn
Jun 30, 2025 4.10 Mn
Mar 31, 2025 5.10 Mn
Dec 31, 2024 3.02 Mn
Sep 30, 2024 3.82 Mn
Jun 30, 2024 2.45 Mn
Mar 31, 2024 3.63 Mn
Dec 31, 2023 3.17 Mn
Sep 30, 2023 5.22 Mn
Jun 30, 2023 2.69 Mn
Mar 31, 2023 2.64 Mn
Dec 31, 2022 3.19 Mn
Sep 30, 2022 5.76 Mn
Jun 30, 2022 5.51 Mn
Mar 31, 2022 4.28 Mn
Dec 31, 2021 6.42 Mn
Sep 30, 2021 3.51 Mn
Jun 30, 2021 4.05 Mn